+ Watch ATHN
on My Watchlist
The Company is a provider of internet-based business services for physician practices.
healthcare will only grow
The press on this company looks dangerously close to advertisement. a bad sign. Fundamentals are also terrible with a forward p/e of >100. Also the idea of automating billing could auto-destruct if there is ever a glitch. It could be revolutionary, but that could also already factored into the share price.
Buying pullback on a leadership stock
Bringing medical records into the 21st century
Cloud computing is relatively new so service providers are treading in slowly but eventually everyone will see that it can be just as secure as hosting it yourself.
Healthcare & IT, Gov regulations = sure bet
Interesting Cloud company for Healthcare
Good business model, good management, good momentum.
ATHN gaining new contracts. PEG is a stratospheric 4.
Expect an acceleration of doctors implementing EMR as they realize they will not be able to compete in the marketplace without EMR.
Extreme overvalued EVS
Should continue leveraging its strong cloud-based and outsourced offerings as the industry adapts these technologies. Would have been smarter to buy on recent dip, but I still am okay buying position here given medium-term opportunities.
The healthcare digitization trend is still going strong and athenahealth is helping lead the way. I like this one over the long haul from here.
Small medical practitioners need tools to save money and be more efficient and this company has them.
Nice play in taking health care records into the 21st century. They target the smaller docs which need the most help.
Athena will announce today or tomorrow that they are purchasing MBNA's former corporate retreat -- a virtual Xanadu. MBNA spent over $130mm building it and now J Bush (CEO) wants to go into the real estate business! What business does a healthcare IT company have speculating in RE or managing a hotel complex?
Too little liquidity and overplayed.
Company has had a nice run but technically now appears a bit ahead of itself. Likely to face increased competition from QSII, MDRX, etc. going forward - seller at $38
they have the right model to succeed.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions